Burzykowski T - Search Results

1

Statistical challenges in the evaluation of surrogate endpoints in randomized trials.

Molenberghs G, Buyse M, Geys H, Renard D, Burzykowski T, Alonso A. Molenberghs G, et al. Among authors: burzykowski t. Control Clin Trials. 2002 Dec;23(6):607-25. doi: 10.1016/s0197-2456(02)00236-2. Control Clin Trials. 2002. PMID: 12505240 Review.

2

A perspective on surrogate endpoints in controlled clinical trials.

Molenberghs G, Burzykowski T, Alonso A, Buyse M. Molenberghs G, et al. Among authors: burzykowski t. Stat Methods Med Res. 2004 Jun;13(3):177-206. doi: 10.1191/0962280204sm362ra. Stat Methods Med Res. 2004. PMID: 15198486

3

Prentice's approach and the meta-analytic paradigm: a reflection on the role of statistics in the evaluation of surrogate endpoints.

Alonso A, Molenberghs G, Burzykowski T, Renard D, Geys H, Shkedy Z, Tibaldi F, Abrahantes JC, Buyse M. Alonso A, et al. Among authors: burzykowski t. Biometrics. 2004 Sep;60(3):724-8. doi: 10.1111/j.0006-341X.2004.00222.x. Biometrics. 2004. PMID: 15339295

4

Surrogate threshold effect: an alternative measure for meta-analytic surrogate endpoint validation.

Burzykowski T, Buyse M. Burzykowski T, et al. Pharm Stat. 2006 Jul-Sep;5(3):173-86. doi: 10.1002/pst.207. Pharm Stat. 2006. PMID: 17080751

5

A unified framework for the evaluation of surrogate endpoints in mental-health clinical trials.

Molenberghs G, Burzykowski T, Alonso A, Assam P, Tilahun A, Buyse M. Molenberghs G, et al. Among authors: burzykowski t. Stat Methods Med Res. 2010 Jun;19(3):205-36. doi: 10.1177/0962280209105015. Epub 2009 Jul 16. Stat Methods Med Res. 2010. PMID: 19608602 Review.

6

An information-theoretic approach for the evaluation of surrogate endpoints based on causal inference.

Alonso A, Van der Elst W, Molenberghs G, Buyse M, Burzykowski T. Alonso A, et al. Among authors: burzykowski t. Biometrics. 2016 Sep;72(3):669-77. doi: 10.1111/biom.12483. Epub 2016 Feb 10. Biometrics. 2016. PMID: 26864244

7

Pseudo-likelihood estimation for a marginal multivariate survival model.

Tibaldi F, Molenberghs G, Burzykowski T, Geys H. Tibaldi F, et al. Among authors: burzykowski t. Stat Med. 2004 Mar 30;23(6):947-63. doi: 10.1002/sim.1664. Stat Med. 2004. PMID: 15027082 Free article.

8

Exploring and validating surrogate endpoints in colorectal cancer.

Burzykowski T, Buyse M, Yothers G, Sakamoto J, Sargent D. Burzykowski T, et al. Lifetime Data Anal. 2008 Mar;14(1):54-64. doi: 10.1007/s10985-007-9079-4. Epub 2008 Jan 20. Lifetime Data Anal. 2008. PMID: 18205045

9

Individual- and trial-level surrogacy in colorectal cancer.

Buyse M, Burzykowski T, Michiels S, Carroll K. Buyse M, et al. Among authors: burzykowski t. Stat Methods Med Res. 2008 Oct;17(5):467-75. doi: 10.1177/0962280207081864. Epub 2008 Feb 19. Stat Methods Med Res. 2008. PMID: 18285439

10

Predicting treatment effect from surrogate endpoints and historical trials: an extrapolation involving probabilities of a binary outcome or survival to a specific time.

Baker SG, Sargent DJ, Buyse M, Burzykowski T. Baker SG, et al. Among authors: burzykowski t. Biometrics. 2012 Mar;68(1):248-57. doi: 10.1111/j.1541-0420.2011.01646.x. Epub 2011 Aug 13. Biometrics. 2012. PMID: 21838732 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters